Wilmington Savings Fund Society FSB Sells 623 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Wilmington Savings Fund Society FSB lowered its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 34.4% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,186 shares of the financial services provider’s stock after selling 623 shares during the quarter. Wilmington Savings Fund Society FSB’s holdings in iShares Biotechnology ETF were worth $157,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently modified their holdings of IBB. Valeo Financial Advisors LLC bought a new position in shares of iShares Biotechnology ETF during the 3rd quarter worth approximately $206,000. Prism Advisors Inc. bought a new position in shares of iShares Biotechnology ETF during the 3rd quarter worth approximately $206,000. SeaCrest Wealth Management LLC lifted its position in shares of iShares Biotechnology ETF by 203.7% during the 3rd quarter. SeaCrest Wealth Management LLC now owns 10,213 shares of the financial services provider’s stock worth $1,487,000 after buying an additional 6,850 shares in the last quarter. SPC Financial Inc. increased its stake in shares of iShares Biotechnology ETF by 2.4% during the 3rd quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock worth $475,000 after purchasing an additional 75 shares during the last quarter. Finally, Good Life Advisors LLC increased its stake in shares of iShares Biotechnology ETF by 59.4% during the 3rd quarter. Good Life Advisors LLC now owns 2,666 shares of the financial services provider’s stock worth $388,000 after purchasing an additional 993 shares during the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of IBB stock opened at $135.47 on Thursday. The company has a 50 day moving average of $135.88 and a 200-day moving average of $141.13. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were paid a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.